Venrock, a Palo Alto, CA-based venture capital firm, closed its latest healthcare focused fund, at $447m.
The biotech fund, led by Bong Koh and Nimish Shah, will presumably continue to invest in such focus areas as:
– Therapeutics-Small Molecules
– Medical Devices
– Diagnostics & New Technologies
The active healthcare portfolio includes Iris Medicine, Biolux, Corvidia, Cyteir Therapeutics, Federation Bio, Element Biosciences, Inscripta, Virta, Encoded Therapeutics, Shockwave Medical, Unity Biotechnology, Aledade, RefleXion Medical, 10X Genomics, Grand Rounds, Impopharma, Adavium Medical, Hua Medicine, Intuity Medical, Intarcia Therapeutics, and Aveo Pharma.
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock invests in and partners with entrepreneurs to build companies across technology and healthcare.
Portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Millennium Pharma, Nest, SlideShare and Tudou.